8-K: Current report
NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
8-K: Current report
8-K: Current report
8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | DEF 14A: Definitive information statements
Coeptis Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Coeptis Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | 8-K: Current report
Coeptis Therapeutics | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
Coeptis Therapeutics | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
Coeptis Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
No Data
No Data